NZa approval for acquisition of Mauritskliniek by CORIUS
Amsterdam, 16 September 2022 – The Dutch Healthcare Authority has given its approval to the proposed acquisition of our portfolio company Mauritskliniek by CORIUS. Mauritskliniek (incl. Kliniek Veldhoven) provides healthcare services in dermatology, varicose veins, proctology, skin therapy and medical-cosmetic care. The Mauritskliniek is located in Amsterdam, The Hague, Nijmegen, Utrecht and Veldhoven. CORIUS is the largest network of dermatology and phlebology practices in Germany and Switzerland.
By acquiring Mauritskliniek, CORIUS geographically expands its European healthcare offerings to the Netherlands. Both the services and vision of Mauritskliniek are perfectly consistent with those of CORIUS.
Heidi Niemöller (CEO CORIUS): “On behalf of all our employees, we are looking forward to welcome Mauritskliniek and Kliniek Veldhoven as new members of CORIUS. We are impressed by the strong positioning and growth Mauritskliniek has realized during the collaboration with Holland Capital. We aim to offer the best possible care for the patients of Mauritskliniek, whereby the exchange of knowledge about treatments and new technologies between doctors of different locations will be important. We thank Holland Capital and the board of Mauritskliniek in their trust, and we are very aware of our responsibility for both employees and patients. We are looking forward to the future.“
Margot Engels (General Manager a.i. Mauritskliniek and Kliniek Veldhoven): “We are very pleased that our clinics become part of CORIUS, while each clinic will keep their own identity. Joining CORIUS enables Mauritskliniek as an organisation to extend its healthcare offerings and deliver an even higher quality of dermatology, phlebology and medical-cosmetic care.”
About CORIUS
CORIUS is a network of dermatology and phlebology practices. Doctors and partners of CORIUS deliver the highest level of quality and apply the most modern technology. An absolute passion for the job and patients is pivotal in the way of working. CORIUS offers their patients holistic and individual treatments, whereby in-house expert knowledge is shared across cross-clinics and colleagues. Employees follow additional education and trainings throughout. CORIUS has 32 practices and employs 139 doctors and 615 employees. About 450.000 patients are treated each year. www.corius.de
About Mauritskliniek
Mauritskliniek is a specialized clinic for dermatology, treatment for varicose veins and medical-cosmetic care. After the acquisition of Kliniek Veldhoven in 2020, the range of cosmetic-care has been further expanded. The clinics are known for high quality and a pleasant way of working. Their values are personal, clear and well organized. The clinics offer both insured and uninsured care. Customer satisfaction is rated with 8.7/10 points, according zorgkaartnederland.nl. www.mauritskliniek.nl
About Holland Capital
Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 150 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful healthcare entrepreneurs in the relevant growth markets.
Holland Capital Fuels Conversational Commerce Advancements and Invests in Conversation24
Rotterdam, 24 August – Investment company Holland Capital announces an investment in Conversation24, the trailblazing omnichannel communication provider focussing on lead conversion, conversational commerce and live chat. The funding round, led by Holland Capital,...
Lopital and Holland Capital join forces to achieve growth
Amsterdam, 21 August 2023 – Holland Capital invests in Lopital, one of the market leaders in the Netherlands in the field of innovative hygiene and mobility tools, active in more than 25 countries. Holland Capital supports the organization in its growth plans by...
Holland Capital supports the growth of Chainresult and Supply Chain Company
Amsterdam, 10 July 2023 - Investment company Holland Capital is investing in Chainresult and Supply Chain Company, two renowned players in the digitalization of the food & agri value chain. The investment by Holland Capital enables the organizations to realize...
Holland Capital invests in terminal home care organization Attenza
Amsterdam, 15 June 2023 – Holland Capital invests in Attenza, a care organization specialized in offering terminal palliative care at home. With the investment Attenza can execute its ambitious growth path. Palliative terminal care The aging population in the...
Holland Capital invests in House of Clouds and Synobsys
Amsterdam, May 9th, 2023 - Holland Capital invests in House of Clouds and Synobsys, two renowned players in the field of Intelligent Automation. Holland Capital's investment ensures that their growth ambitions can be realised. Intelligent Automation Intelligent...
Holland Capital sells its stake in Valori
Amsterdam/Utrecht, 4 April 2023 – Holland Capital sells its stake in Valori to Cerios. Valori believes that embedding integral quality into IT systems is crucial to allow carefree innovation. The Quality Assurance and Test Consultants of Valori build towards the...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 311 94 11
Düsseldorf
Inselstraße 34
40479 Düsseldorf
+49 (0) 211 43 63 69 01





